Ethics statement The studies involving humans were approved by the University of Surrey Ethics Committee and a favorable ethical opinion was granted, reference FHMS 2122,026 EGAAmend 3
These measures reduce immediate swelling and discomfort
If results are weak into the remodeling phase and starting dose was sub-3.2 mg, a dose increase and protocol modification may be warranted
The science , simplified The science , simplified Quality comes first Quality comes first To ensure proper safety and accuracy, a state-licensed, board-certified MD, DO, or qualified medical provider reviews your intake and creates a plan specifically for you
Not intended for medical, diagnostic, therapeutic, or human consumption use